A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- How a new library is set to transform this underserved N.J. community
- Poll Finds Majority of New Jerseyans Give Negative Ratings to State and National Economy.
- New NJACTS Publication
- One Rule Change Would Help Tens of Thousands of New Jersey Families Pay for Childcare
- Advanced Models Offer Scientists a Promising Tool to Better Understand Brain Disorders
Categories
- Community (2,242)
- Covid (985)
- CTO Events (6)
- News (2,857)
- Pilots (21)